⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CERO News

CERo Therapeutics Holdings, Inc. Common Stock

CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML